References
- Meritt HH, Putnam JJ. Experimental determination of the anticonvulsant properties of some phenyl derivatives. Science 1937;85:525–526.
- Brodie MJ. Established anticonvulsants and treatment of refractory epilepsy. Lancet 1990;336:350–354.
- Eadia MJ. Anticonvulsant drugs: An update. Drugs 1984;27:328–363.
- Ragavendran JV, Sriram D, Patel SK, Reddy IV, Bharathwajan N, Stables J et al. Design and synthesis of anticonvulsants from a combined phthalimide-GABA-anilide and hydrazone pharmacophore. Eur J Med Chem 2007;42:146–151.
- Arzu K, Meral O, Şamil I, James PS, Sevim D. Synthesis, anticonvulsant and antimicrobial activities of some new 2-acetylnaphthalene derivatives. Bioorg Med Chem2010;18:2902–2911.
- Ergenc N, Gunay NS. Synthesis and antidepressant evaluation of new 3-phenyl-5-sulfonamidoindole derivatives. Eur J Med Chem 1998;33:143–148.
- Duarte CD, Tributino JL, Lacerda DI, Martins MV, Alexandre-Moreira MS, Dutra F et al. Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors. Bioorg Med Chem 2007;15:2421–2433.
- Bernardino AM, Gomes AO, Charret KS, Freitas AC, Machado GM, Canto-Cavalheiro MM et al. Synthesis and leishmanicidal activities of 1-(4-X-phenyl)-N’-[(4-Y-phenyl)methylene]-1H-pyrazole-4-carbohydrazides. Eur J Med Chem 2006;41:80–87.
- Imramovský A, Polanc S, Vinsová J, Kocevar M, Jampílek J, Recková Z et al. A new modification of anti-tubercular active molecules. Bioorg Med Chem 2007;15:2551–2559.
- Rollas S, Gulerman N, Erdeniz H. Synthesis and antimicrobial activity of some new hydrazones of 4-fluorobenzoic acid hydrazide and 3-acetyl-2,5-disubstituted-1,3,4-oxadiazolines. Farmaco 2002;57:171–174.
- Cakir B, Dag O, Yildirim E, Erol K, Sahin MF. Synthesis and anticonvulsant activity of some hydrazones of 2-[(3H)-oxobenzoxazolin-3-yl-aceto]hydrazide. J Fac Pharm Gazi 2001;18:99–106.
- Yogeeswari P, Sriram D, Thirumurugan R, Raghavendran JV, Sudhan K, Pavana RK et al. Discovery of N-(2,6-dimethylphenyl)-substituted semicarbazones as anticonvulsants: hybrid pharmacophore-based design. J Med Chem 2005;48:6202–6211.
- Phase, version 3.1, Schrodinger, LLC, New York, NY, 2009.
- Krall RL, Penry JK, White BG, Kupferberg HJ, Swinyard EA. Antiepileptic drug development: II. Anticonvulsant drug screening. Epilepsia 1978;19:409–428.
- Löscher W, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res 1991;8:79–94.
- Porter RJ, Cereghino JJ, Gladding GD, Hessie BJ, Kupferberg HJ, Scoville B et al. Antiepileptic Drug Development Program. Cleve Clin Q 1984;51:293–305.
- Yogeeswari P, Sriram D, Saraswat V, Ragavendran JV, Kumar MM, Murugesan S et al. Synthesis and anticonvulsant and neurotoxicity evaluation of N4-phthalimido phenyl (thio) semicarbazides. Eur J Pharm Sci 2003;20:341–346.
- Porsolt RD, Anton G, Blavet N, Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur J Pharmacol 1978;47:379–391.
- Kappe CO. 100 years of the biginelli dihydropyrimidine synthesis. Tetrahedron 1993;49:6937.
- Arpana R, Nadeem S, Suroor AK, Haque SE, Bhat MA. N-{[(6-Substituted-1,3-benzothiazole-2-yl)amino]carbonothioyl}-2/4-substituted benzamides: Synthesis and pharmacological evaluation. Eur J Med Chem 2008;43:1114–1122.
- Flaherty PT, Greenwood TD, Manheim AL, Wolfe JF. Synthesis and evaluation of N-(phenylacetyl)trifluoromethanesulfonamides as anticonvulsant agents. J Med Chem 1996;39:1509–1513.